Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach.

Clin Epidemiol 2018 14;10:1869-1877. Epub 2018 Dec 14.

Health Statistics Group, University of Exeter Medical School, Exeter, UK,

Objective: Precision medicine drug therapy seeks to maximize efficacy and minimize harm for individual patients. This will be difficult if drug response and side effects are positively associated, meaning that patients likely to respond best are at increased risk of side effects. We applied joint longitudinal-survival models to evaluate associations between drug response (longitudinal outcome) and the risk of side effects (survival outcome) for patients initiating type 2 diabetes therapy.

Study Design And Setting: Participants were randomized to metformin (MFN), sulfonylurea (SU), or thiazolidinedione (TZD) therapy in the A Diabetes Outcome Progression Trial (ADOPT) drug efficacy trial (n=4,351). Joint models were parameterized for 1) current HbA1c response (change from baseline in HbA1c) and 2) cumulative HbA1c response (total HbA1c change).

Results: With MFN, greater HbA1c response did not increase the risk of gastrointestinal events (HR per 1% absolute greater current response 0.82 [95% CI 0.67, 1.01]; HR per 1% higher cumulative response 0.90 [95% CI 0.81, 1.00]). With SU, greater current response was associated with an increased risk of hypoglycemia (HR 1.41 [95% CI 1.04, 1.91]). With TZD, greater response was associated with an increased risk of edema (current HR 1.45 [95% CI 1.05, 2.01]; cumulative 1.22 [95% CI 1.07, 1.38]) but not fracture.

Conclusion: Joint modeling provides a useful framework to evaluate the association between response to a drug and the risk of developing side effects. There may be great potential for widespread application of joint modeling to evaluate the risks and benefits of both new and established medications.

Download full-text PDF

Source
http://dx.doi.org/10.2147/CLEP.S179555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298877PMC
December 2018
2 Reads

Publication Analysis

Top Keywords

side effects
16
joint modeling
12
hba1c response
12
increased risk
12
response
10
risk side
8
response associated
8
drug response
8
drug therapy
8
greater current
8
associated increased
8
current response
8
type diabetes
8
risk
6
drug
6
hba1c
5
[95%
5
joint
5
response increase
4
increase risk
4

Similar Publications